Cognoptix Co-Founder Lee Goldstein, M.D., Ph.D. Joins Cognoptix Board of Directors and Scientific Advisory Board

Cognoptix, a leading healthcare company for early-stage detection of Alzheimer’s disease (AD), announces its co-founder, Lee Goldstein, M.D., Ph.D. has joined Cognoptix’s Scientific Advisory Board, serving as Co-Chair, and the company’s Board of Directors. Read more >>